264 related articles for article (PubMed ID: 33459993)
21. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
[TBL] [Abstract][Full Text] [Related]
22. Atypical/unbalanced ETV6/NTRK3 rearrangement in salivary secretory carcinoma with a focus on the incidence, the patterns, and the clinical implications.
Sun J; Li J; Tian Z; Zhang C; Xia R; He Y
J Oral Pathol Med; 2022 Sep; 51(8):721-729. PubMed ID: 36087274
[TBL] [Abstract][Full Text] [Related]
23. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
[TBL] [Abstract][Full Text] [Related]
24. A Parotid Gland Mammary Analogue Secretory Carcinoma in a 4-Year-Old Boy: Case Report and Literature Review.
Meng Z; Si W; Xiuli Z; Liu Y
Fetal Pediatr Pathol; 2023 Apr; 42(2):342-350. PubMed ID: 36053082
[No Abstract] [Full Text] [Related]
25. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
[TBL] [Abstract][Full Text] [Related]
26. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
27. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
Su YJ; Lee YH; Jin YT; Hsieh MS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
[TBL] [Abstract][Full Text] [Related]
28. Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases.
Dettloff J; Seethala RR; Stevens TM; Brandwein-Gensler M; Centeno BA; Otto K; Bridge JA; Bishop JA; Leon ME
Head Neck Pathol; 2017 Jun; 11(2):124-130. PubMed ID: 27400918
[TBL] [Abstract][Full Text] [Related]
29. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
30. Mammary analogue secretory carcinoma of parotid: Is preoperative cytological diagnosis possible?
Oza N; Sanghvi K; Shet T; Patil A; Menon S; Ramadwar M; Kane S
Diagn Cytopathol; 2016 Jun; 44(6):519-25. PubMed ID: 26945684
[TBL] [Abstract][Full Text] [Related]
31. Mammary Analogue Secretory Carcinoma.
Parekh V; Stevens TM
Arch Pathol Lab Med; 2016 Sep; 140(9):997-1001. PubMed ID: 27575269
[TBL] [Abstract][Full Text] [Related]
32. The screening and electron microscopy observation of mammary analogue secretory carcinoma in Chinese.
Zhong Y; Liu L; Qi B; Song X; Shen L; Li H
J Craniomaxillofac Surg; 2018 Jun; 46(6):893-897. PubMed ID: 29752049
[TBL] [Abstract][Full Text] [Related]
33. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M
Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788
[TBL] [Abstract][Full Text] [Related]
34. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
35. Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics.
Luk PP; Selinger CI; Eviston TJ; Lum T; Yu B; O'Toole SA; Clark JR; Gupta R
Pathology; 2015 Dec; 47(7):659-66. PubMed ID: 26517645
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.
Boon E; Valstar MH; van der Graaf WTA; Bloemena E; Willems SM; Meeuwis CA; Slootweg PJ; Smit LA; Merkx MAW; Takes RP; Kaanders JHAM; Groenen PJTA; Flucke UE; van Herpen CML
Oral Oncol; 2018 Jul; 82():29-33. PubMed ID: 29909898
[TBL] [Abstract][Full Text] [Related]
37. Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion.
Dogan S; Wang L; Ptashkin RN; Dawson RR; Shah JP; Sherman EJ; Michael Tuttle R; Fagin JA; Klimstra DS; Katabi N; Ghossein RA
Mod Pathol; 2016 Sep; 29(9):985-95. PubMed ID: 27282352
[TBL] [Abstract][Full Text] [Related]
38. Primary Mammary Analog Secretory Carcinoma (MASC) of the Vulva With ETV6-NTRK3 Fusion: A Case Report.
Nguyen JK; Bridge JA; Joshi C; McKenney JK
Int J Gynecol Pathol; 2019 May; 38(3):283-287. PubMed ID: 29672325
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic and molecular genetic analysis of secretory carcinoma of salivary gland].
Zhao M; Zhao DH; Cheng G; Yan YJ; Wang Z; He XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):533-538. PubMed ID: 30078266
[No Abstract] [Full Text] [Related]
40. Secretory Carcinoma with ETV6-NTRK3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
